MYH9 and melanoma: An additional study found that genetically knocking down MYH9 in mouse melanoma cells increased growth and metastasis in vivo in mouse models which was attributed to increased epithelial to mesenchymal (EMT) markers and potentially increased angiogenesis and inflammatory cell recruitment [51].